US lingerie company Victoria’s Secret has reached a settlement in a lawsuit over the sale of knockoff products that mimic the get-up of its trade marked body care products.
F. Hoffman La-Roche has reached a settlement in a patent lawsuit over Sandoz’s plan to market a biosimilar version of its patented biologic used to treat various cancers and rheumatoid arthritis.
The takeover battle for Xenith IP has entered round two, with IPH submitting a revised proposal to acquire the IP services firm in full, leaving fellow suitor QANTM with three days to lodge a competing offer.
Funding for a shareholder class action against mineral sands company Iluka Resources is in doubt after Harbour Litigation Funding unilaterally backed out of an agreement to finance the litigation.
A judge has rejected a bid by former directors of Slater & Gordon to throw out cross claims brought by Pitcher Partners in two shareholder class actions alleging the accounting firm wrongly signed off on the law firm’s financial reports ahead of a share price nosedive, saying it was possible Pitcher Partners’ claimed reliance on representations by the directors was reasonable.
Global pharmaceutical giant Lundbeck has launched a bid to escape a prior undertaking blocking it from appealing a court’s decision that allowed four generic drug makers to apply for licences to manufacture generic versions of popular antidepressant Lexapro.
Charges in the criminal cartel case against ANZ, Citigroup and Deutsche Bank over a $2.5 billion ANZ institutional share placement have yet to be finalised, almost a year after the proceeding was filed.
Liquidators of failed Centaur Litigation have reached a settlement in their lawsuit against the accountant of fraudster Scott Williams, who was accused of lying to hide his knowledge of a Ponzi scheme that misappropriated $32 million and led to the collapse of the funder.
Telecom giant Optus has been hit with a $25,000 criminal fine after pleading guilty to four charges of failing to disclose political donations in its development applications.
ANZ Bank executives briefly considered relaunching and repricing a botched $2.5 billion equity capital raising at the heart of two groundbreaking enforcement actions, and the decision by the share placement’s underwriters to instead pick up a $790 million shortfall deprived investors of lower priced shares, a court has been told.